Novartis Ag (NVSEF) Shares Outstanding (Diluted Average) (2009 - 2026)

Novartis Ag has disclosed Shares Outstanding (Diluted Average) across 16 years of filings, most recently posting $1.65 for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $1.65, down 9.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.65 (down 9.34% YoY), and the FY2025 annual result was $7.15, up 21.81% from the prior year.
• Shares Outstanding (Diluted Average) came in at $1.65 for Q1 2026 at Novartis Ag, down from $7.15 in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $2.2 billion in Q2 2022 to a low of $0.99 in Q1 2022.
• The 5-year median for Shares Outstanding (Diluted Average) is $2.83 (2023), against an average of $130.1 million.
• Across the five-year window, Shares Outstanding (Diluted Average) slumped 100.0% in 2023 and surged 165.14% in 2024, its largest moves.
• Novartis Ag's Shares Outstanding (Diluted Average) stood at $2.75 in 2022, then soared by 49.09% to $4.1 in 2023, then surged by 43.17% to $5.87 in 2024, then gained by 21.81% to $7.15 in 2025, then tumbled by 76.92% to $1.65 in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $1.65 (Q1 2026), $7.15 (Q4 2025), and $5.9 (Q3 2025), per Business Quant data.